Effect of Transforming Growth Factor-β Inhibition on Ureteral and Renal Scarring in a Rat Model of Upper Urinary Tract Ablation with Irreversible Electroporation
Adjuvant PFD can reduce myofibroblast activity and ureteral fibrosis at the site of IRE ablation, enabling safe soft tissue ablation adjacent or involving the upper urinary tract.
Authors
- Govindarajan Srimathveeravalli (ORCID: https://orcid.org/0000-0001-8885-3830)
- Takaaki Hasegawa
- Badar M. Mian (ORCID: https://orcid.org/0000-0002-1698-9525)
- Arjun Sivaraman (ORCID: https://orcid.org/0000-0002-2185-3681)
- Jonathan Coleman (ORCID: https://orcid.org/0000-0002-6428-7835)
- Laurien G. P. H. Vroomen (ORCID: https://orcid.org/0000-0002-0932-092X)
- Masashi Fujimori (ORCID: https://orcid.org/0000-0002-8244-3176)
- Nirmal Thampi John
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Christian Medical College, Vellore (IN)
- Mie University (JP)
- Medical College of Wisconsin (US)
- University of Massachusetts Amherst (US)
- Amsterdam Neuroscience (NL)
- Albany Medical Center Hospital (US)
Publication Details
- Journal
- Bioelectricity
- Published
- 2024-09-12
- DOI
- https://doi.org/10.1089/bioe.2024.0022
- Primary Topic
- Microbial Inactivation Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Memorial Sloan-Kettering Cancer Center
- Vrije Universiteit Amsterdam